Joseph P. McElroy, Ph.D.
Affiliations: | 2005 | Iowa State University, Ames, IA, United States |
Area:
Genetics, Agronomy Agriculture, Animal Pathology AgricultureGoogle:
"Joseph McElroy"Parents
Sign in to add mentor| Jack C. M. Dekkers | grad student | 2005 | Iowa State | |
| (Mapping quantitative trait loci for economic traits in chickens.) | ||||
BETA: Related publications
See more...
Publications
|
You can help our author matching system! If you notice any publications incorrectly attributed to this author, please sign in and mark matches as correct or incorrect. |
| Bell EH, Zhang P, Shaw EG, et al. (2020) Comprehensive Genomic Analysis in NRG Oncology/RTOG 9802: A Phase III Trial of Radiation Versus Radiation Plus Procarbazine, Lomustine (CCNU), and Vincristine in High-Risk Low-Grade Glioma. Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology. JCO1902983 |
| Bell EH, Pugh SL, Fisher BJ, et al. (2020) Long-term analysis of the WHO-defined molecular subgroups of high-risk grade II gliomas treated with radiation and temozolomide on NRG Oncology/RTOG 0424. Journal of Clinical Oncology. 38: 2518-2518 |
| Boru G, Grosel TW, Pilarski R, et al. (2019) Germline large deletion of BAP1 and decreased expression in non-tumor choroid in uveal melanoma patients with high risk for inherited cancer. Genes, Chromosomes & Cancer |
| Fabian D, Bell EH, McElroy JP, et al. (2019) A preliminary comprehensive molecular-based nomogram for individualized estimation of survival in patients with newly diagnosed glioblastoma utilizing global microRNA expression data. Journal of Clinical Oncology. 37: 2044-2044 |
| Beyer SJ, Bell EH, McElroy JP, et al. (2018) Oncogenic is differentially regulated in wild-type vs. mutant gliomas. Oncotarget. 9: 37097-37111 |
| Cui T, Bell EH, McElroy J, et al. (2018) miR-4516 predicts poor prognosis and functions as a novel oncogene via targeting PTPN14 in human glioblastoma. Oncogene |
| Bell EH, Zhang P, Fisher BJ, et al. (2018) Association of MGMT Promoter Methylation Status With Survival Outcomes in Patients With High-Risk Glioma Treated With Radiotherapy and Temozolomide: An Analysis From the NRG Oncology/RTOG 0424 Trial. Jama Oncology |
| Cui T, Gray A, Bell EH, et al. (2018) CSIG-24. miR-575 IS ASSOCIATED WITH WORSE SURVIVAL OF GBM PATIENTS AND ACTS AS A NOVEL ONCOGENE THROUGH TARGETING p27/CDKN1B AND BLID/BRCC2 Neuro-Oncology. 20 |
| Fleming J, McElroy J, Bell EH, et al. (2018) Elevated MGMT Gene Expression is Independently Associated with Worse Overall Survival in NRG Oncology/RTOG 9813: A Phase III Study of Radiation Therapy (RT) and Temozolomide (TMZ) Versus RT and Nitrosourea (NU) in Anaplastic Grade III Glioma International Journal of Radiation Oncology Biology Physics. 102 |
| Becker AP, Bell EH, Fleming J, et al. (2017) Comprehensive assessment of ATRX mutation, protein expression, and alternative lengthening of telomeres (ALT) phenotype in grade II and III gliomas. Journal of Clinical Oncology. 35: 2064-2064 |